|
Net sales
|
|
$368.7m
|
$504.2m
|
$692.8m
|
$688.4m
|
$659.7m
|
$602.2m
|
$613.5m
|
|
Cost of goods sold
|
|
$219.9m
|
$295.9m
|
$406.0m
|
$434.8m
|
$403.6m
|
$363.7m
|
$347.3m
|
|
Gross profit
|
|
$148.8m
|
$208.2m
|
$286.8m
|
$253.7m
|
$256.1m
|
$238.5m
|
$266.2m
|
|
Selling, general, and administrative
|
|
$62.4m
|
$70.9m
|
$116.8m
|
$150.7m
|
$120.2m
|
$132.1m
|
$146.1m
|
|
Operating income
|
|
$46.1m
|
$85.5m
|
$77.5m
|
$50.7m
|
$94.0m
|
$14.7m
|
$82.5m
|
|
Amortization of intangible assets
|
|
$10.5m
|
$11.1m
|
$14.0m
|
$14.7m
|
$14.6m
|
$13.9m
|
$13.8m
|
|
Impairment of indefinite-lived intangible assets
|
|
—
|
$0
|
$0
|
$2.4m
|
$0
|
$7.7m
|
$0
|
|
Impairment of goodwill
|
|
—
|
—
|
—
|
$0
|
$0
|
$40.9m
|
$0
|
|
Loss on sale of assets
|
|
—
|
—
|
—
|
—
|
—
|
$9.2m
|
$0
|
|
Change in fair value of warrant liability
|
|
—
|
$0
|
$32.6m
|
($57.0m)
|
$4.1m
|
($7.6m)
|
$1.2m
|
|
Change in fair value of earn-out liability
|
|
—
|
$0
|
$8.9m
|
($10.7m)
|
$2.3m
|
($2.3m)
|
$897k
|
|
Loss (gain) on early extinguishment of debt
|
|
—
|
$0
|
($13.7m)
|
$0
|
($701k)
|
$141k
|
($93k)
|
|
Income (loss) before income taxes
|
|
($4.3m)
|
$41.7m
|
($16.7m)
|
$78.3m
|
$27.6m
|
($26.3m)
|
$28.6m
|
|
Foreign currency translation adjustment
|
|
—
|
$16k
|
$30k
|
($990k)
|
$234k
|
($452k)
|
$1.3m
|
|
Total other comprehensive income (loss)
|
|
—
|
($277k)
|
$418k
|
($688k)
|
$234k
|
($452k)
|
$1.3m
|
|
Total comprehensive income (loss)
|
|
$438k
|
$32.6m
|
($26.7m)
|
$73.1m
|
$19.4m
|
($23.7m)
|
$20.5m
|
|
Net income (loss)
|
|
$561k
|
$32.9m
|
($27.1m)
|
$73.8m
|
$19.2m
|
($23.2m)
|
$19.2m
|
|
Basic net income (loss) per share ((in usd per share))
|
|
$0
|
$0
|
($0)
|
$1
|
$0
|
($0)
|
$0
|
|
Diluted net income (loss) per share (in usd per share)
|
|
$0
|
$0
|
($0)
|
$0
|
$0
|
($0)
|
$0
|
|
Weighted average common shares outstanding - basic (in shares)
|
|
—
|
67.7m
|
90.0m
|
116.8m
|
117.4m
|
118.4m
|
119.2m
|
|
Weighted average common shares outstanding - diluted (in shares)
|
|
—
|
67.7m
|
90.0m
|
117.2m
|
118.5m
|
118.4m
|
120.0m
|
|
Research and development costs
|
|
$20.6m
|
$23.5m
|
$28.3m
|
$29.1m
|
$23.8m
|
$18.7m
|
$18.8m
|
|
Restructuring costs
|
|
—
|
—
|
—
|
$4.5m
|
$2.6m
|
$1.6m
|
$2.9m
|
|
Other operating expense (income)
|
|
$644k
|
$1.5m
|
$755k
|
$1.5m
|
$765k
|
($268k)
|
$2.1m
|
|
Interest expense, net
|
|
—
|
—
|
($39.1m)
|
($40.2m)
|
($60.7m)
|
($50.7m)
|
($51.8m)
|
|
Income tax expense (benefit)
|
|
($4.9m)
|
$8.8m
|
$10.4m
|
$4.5m
|
$8.4m
|
($3.0m)
|
$9.5m
|
|
Total operating expense
|
|
$102.7m
|
$122.8m
|
$209.3m
|
$202.9m
|
$162.1m
|
$223.9m
|
$183.8m
|
|
Total non-operating expense
|
|
$50.4m
|
$43.8m
|
$94.2m
|
($27.5m)
|
$66.5m
|
$40.9m
|
$53.8m
|